HR6117-119

Introduced

To amend the Federal Food, Drug, and Cosmetic Act to authorize requiring the manufacturers of a covered device to disclose to a patient all patient-specific data that is recorded or transmitted by the device and accessible to the manufacturer, and for other purposes.

119th Congress Introduced Nov 18, 2025

Legislative Progress

Introduced
Introduced Committee Passed
Nov 18, 2025

Ms. Sherrill introduced the following bill; which was referred to …

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology